| Protein‐protein interactions as a target for drugs in proteomics AI Archakov, VM Govorun, AV Dubanov, YD Ivanov, AV Veselovsky, ... Proteomics 3 (4), 380-391, 2003 | 267 | 2003 |
| Protein–protein interactions: mechanisms and modification by drugs AV Veselovsky, YD Ivanov, AS Ivanov, AI Archakov, P Lewi, P Janssen Journal of Molecular Recognition 15 (6), 405-422, 2002 | 160 | 2002 |
| Strategy of computer-aided drug design AV Veselovsky, AS Ivanov Current Drug Targets-Infectious Disorders 3 (1), 33-40, 2003 | 158 | 2003 |
| Molecular docking studies of HIV-1 resistance to reverse transcriptase inhibitors: mini-review O Tarasova, V Poroikov, A Veselovsky Molecules 23 (5), 1233, 2018 | 56 | 2018 |
| Identification of Functional Regions in the Rhodospirillum rubrum l-Asparaginase by Site-Directed Mutagenesis MV Pokrovskaya, SS Aleksandrova, VS Pokrovsky, AV Veselovsky, ... Molecular biotechnology 57, 251-264, 2015 | 55 | 2015 |
| Inhibition of monoamine oxidase by pirlindole analogues: 3D-QSAR and CoMFA analysis AE Medvedev, AV Veselovsky, VI Shvedov, OV Tikhonova, TA Moskvitina, ... Journal of chemical information and computer sciences 38 (6), 1137-1144, 1998 | 55 | 1998 |
| QSAR analysis of indole analogues as monoamine oxidase inhibitors AE Medvedev, AS Ivanov, AV Veselovsky, VS Skvortsov, AI Archakov Journal of chemical information and computer sciences 36 (4), 664-671, 1996 | 52 | 1996 |
| Disordering of human telomeric G-quadruplex with novel antiproliferative anthrathiophenedione D Kaluzhny, N Ilyinsky, A Shchekotikhin, Y Sinkevich, PO Tsvetkov, ... PLoS One 6 (11), e27151, 2011 | 50 | 2011 |
| Renalase, a new secretory enzyme responsible for selective degradation of catecholamines: achievements and unsolved problems AE Medvedev, AV Veselovsky, VI Fedchenko Biochemistry (Moscow) 75, 951-958, 2010 | 50 | 2010 |
| Novel oxazolinyl derivatives of pregna-5, 17 (20)-diene as 17α-hydroxylase/17, 20-lyase (CYP17A1) inhibitors AV Kuzikov, NO Dugin, SV Stulov, DS Shcherbinin, MS Zharkova, ... Steroids 88, 66-71, 2014 | 48 | 2014 |
| Bioinformatics platform development: from gene to lead compound AS Ivanov, AV Veselovsky, AV Dubanov, VS Skvortsov Bioinformatics and Drug Discovery, 389-431, 2006 | 44 | 2006 |
| Analysis of redox activity of proteins on the carbon screen printed electrodes EV Suprun, MS Zharkova, GE Morozevich, AV Veselovsky, ... Electroanalysis 25 (9), 2109-2116, 2013 | 43 | 2013 |
| Computer-aided design of aptamers for cytochrome p450 DS Shcherbinin, OV Gnedenko, SA Khmeleva, SA Usanov, AA Gilep, ... Journal of structural biology 191 (2), 112-119, 2015 | 36 | 2015 |
| Inhibitors of protein-protein interactions as potential drugs AV Veselovsky, AI Archakov Current Computer-Aided Drug Design 3 (1), 51-58, 2007 | 36 | 2007 |
| Oxazolinyl derivatives of [17 (20) E]-21-norpregnene differing in the structure of A and B rings. Facile synthesis and inhibition of CYP17A1 catalytic activity VA Kostin, VA Zolottsev, AV Kuzikov, RA Masamrekh, VV Shumyantseva, ... Steroids 115, 114-122, 2016 | 34 | 2016 |
| Methionine to isothreonine conversion as a source of false discovery identifications of genetically encoded variants in proteogenomics AL Chernobrovkin, AT Kopylov, VG Zgoda, AA Moysa, MA Pyatnitskiy, ... Journal of proteomics 120, 169-178, 2015 | 33 | 2015 |
| The role of the Ω-loop in regulation of the catalytic activity of TEM-type β-lactamases A Egorov, M Rubtsova, V Grigorenko, I Uporov, A Veselovsky Biomolecules 9 (12), 854, 2019 | 30 | 2019 |
| Computer modelling and visualization of active site of monoamine oxidases AV Veselovsky, AS Ivanov, AE Medvedev Neurotoxicology 25 (1-2), 37-46, 2004 | 29 | 2004 |
| Human urinary renalase lacks the N-terminal signal peptide crucial for accommodation of its FAD cofactor VI Fedchenko, OA Buneeva, AT Kopylov, AV Veselovsky, VG Zgoda, ... International journal of biological macromolecules 78, 347-353, 2015 | 27 | 2015 |
| In vitro interactions of abiraterone, erythromycin, and CYP3A4: implications for drug–drug interactions RA Masamrekh, AV Kuzikov, YI Haurychenka, KA Shcherbakov, ... Fundamental & clinical pharmacology 34 (1), 120-130, 2020 | 22 | 2020 |
Alexis IvanovInstitute of Biomedical Chemistry, Moscow, RussiaVerified email at ibmc.msk.ru
